BrainCool AB (5YL) AI Stock Analysis

2 Followers

BrainCool AB

(Frankfurt:5YL)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Revenue GrowthStrong trailing revenue growth indicates increasing commercial activity and customer demand for the company’s products. If maintained, this expansion can improve operating leverage, support broader market adoption, and provide a larger base from which future profitability may develop.

Negative Factors

Negative Gross ProfitNegative gross profit means current revenue does not cover the direct cost of delivering products, making growth economically dilutive rather than inherently value creating. Sustainable improvement requires significant changes in pricing, product economics, or costs before higher sales can translate into durable earnings.

BrainCool AB (5YL) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 39.89M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -12.4
Beta (1Y): 1.10
Revenue Growth: 2.72%
EPS Growth: 32.54%
Country: Germany
Employees: 15
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Devices

BrainCool AB Business Overview & Revenue Model

Company Description

BrainCool AB (publ), a medical technology company founded in 2010 and headquartered in Lund, Sweden, focuses on the development, commercialization, and distribution of advanced medical cooling systems. Operating with its subsidiaries, the company cat...

BrainCool AB Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:5YL against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SE:GETI.B	67Neutral	SEK 76.26B	27.10	9.13%	1.69%	-3.90%	37.73%
SE:XVIVO	64Neutral	SEK 6.39B	50.37	5.89%	―	17.83%	330.94%
SE:PAX	60Neutral	SEK 1.45B	-309.35	-1.22%	―	34.05%	-144.96%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
SE:SEDANA	49Neutral	SEK 894.03M	-26.31	-3.88%	―	0.42%	15.03%
SE:OSSD	45Neutral	SEK 387.19M	-7.74	―	―	-11.89%	-11.85%

* Healthcare Sector Average

Performance Comparison

DE:5YL and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:5YL	BrainCool AB	0.08	0.05	159.38%
SE:GETI.B	Getinge AB (UK)	281.60	74.49	35.96%
SE:PAX	Paxman AB	67.50	6.90	11.39%
SE:XVIVO	Xvivo Perfusion AB	206.00	42.50	25.99%
SE:SEDANA	Sedana Medical AB	9.14	-0.37	-3.89%
SE:OSSD	OssDsign AB	3.50	-7.48	-68.12%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

BrainCool AB AI Stock Analysis